Hap had his third treatment of the clinical trial that he is in. (Phase II Trial of CCI-779 and Bevacizumab)
The trial is a combination of Bevacizumab (Avastin) and a chemotherapy drug, Temsirolimus.
Side effects to this point include headaches, nose bleeds, nausea, weight loss and fatigue.

(even treatments don't keep Hap from his phone)

(but Benadryl does....)

Hap has blood work, weights and blood pressure checked weekly. This past week he lost six more pounds. After two months the treatment will be evaluated by scans to determine any tumor progression or shrinkage. At that time doctors will determine if Hap stays in the trial or discontinues.

Meanwhile Hap and Mary found out that there is a new neuroendocrine center in Nashville, Tennessee at the Vanderbilt campus. They now have the Galium68 scan which was only available in Europe. http://www.vanderbilthealth.com/neuroendocrine/36265
This scan is necessary to determine the level of the cancer uptake. This would be needed in the event that Hap needs to go to Sweden for PRRT (Peptide Radio Receptor Therapy) They have asked Hap’s oncologist to contact the doctor at Vanderbilt and she was completely on board with that.

Hap and Mary are very grateful to family and friends for their continuous prays, help with rides, surprise meals, muffins by the dozens and cards of encouragement.